Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Control group: will received an oral contraceptives for 3 menstrual cycles from the 5th day of menstruation for a period of 21 days. Intervention 2: Intervention group: an oral contra
Treatment - Drugs
Control group: will received an oral contraceptives for 3 menstrual cycles from the 5th day of menstruation for a period of 21 days.
Intervention group: an oral contraceptives per day with continuous treatment of 700mgs herbal medicine per day for 3 months.
Sponsors
Vice chancellor for Research,Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: In case of the diagnosis of polycystic ovary syndrome the consent form will taken and include to study Exclusion criteria: In case of drug intolerance or dissatisfaction in any stage of the study and body mass index above 30; they are free to withdraw any time.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms of hirsutism. Timepoint: 3 and 6 months after treatment. Method of measurement: Ultrasound and tests.;Clinical symptoms of acene. Timepoint: 3 and 6 months after treatment. Method of measurement: Ultrasound and tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAliye Ghasemzadeh
Tabriz University Of Medical Sciences
Outcome results
None listed